PERSPECTIVE: Observational Studies of Drugs and Mortality
1st Dec 2005, 00:47 GMT
Randomized controlled trials of therapies for the primary and secondary prevention of cardiovascular disease increasingly are powered to study overall mortality. The interventions frequently treat asymptomatic risk factors among high-risk ...
PERSPECTIVE: Observational Studies of Drugs and Mortality related news:
- Stents do not reduce mortality — The Cardio Blog
- Doctor says Vioxx can cause heart attacks — SacBee -- Business News
- ORIGINAL ARTICLE: Risk of Death in Elderly Users of Conventional vs. Atypical Antipsychotic Medications — New England Journal of Medicine
- What Robinson really said — The Irish Times' Opinion Top Stories
- Virological Control during the First 6-18 Months after Initiating Highly Active Antiretroviral Therapy as a Predictor for Outcome in HIV-Infected Patients: A Danish, Population-Based, 6-Year Follow-Up Study — Clin Infect Dis Latest Articles
- Volume 42, number 1: Virological Control during the First 6-18 Months after Initiating Highly Active Antiretroviral Therapy as a Predictor for Outcome in HIV-Infected Patients: A Danish, Population-Based, 6-Year Follow-Up Study — Clin Infect Dis Latest Issue
- In the Elderly, Conventional Antipsychotics May Be Associated With Increased Mortality — Medscape Nursing Headlines
- Inhaled steroids reduce mortality in COPD — Reuters: Health
- CORONARY EFFECTS OF COMBUSTION-SOURCE PARTICULATE MATTER (R830839) — Recent EPA Catalog Records.
- Cindy Crawford's drug scare — iac entertainment news